Subscribe to Email Alerts
Menu
About Us
About INOVIQ
Market Opportunity
Board
Management
Medical & Scientific Advisory Board
Partners
Distributors
Compliance
Careers
Technology
Our Science
NETs Platform
SubB2M Platform
BARD1 Biomarker Technology
hTERT ICC Assay
Intellectual Property
Publications
Resources
Business Development
Products
Our Products
EXO-NET® Pan-Exosome
Product Overview
Technical Information
Data & Figures
Ordering
hTERT ICC Test
Pipeline
Development Pipeline
NeuCA15-3 Test
NeuCA125 Test
EXO-Ovarian Cancer Test
Exosome Therapeutics
Investors
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
News & Events
INOVIQ in the News
Conferences & Events
Contact
Contact Us
Subscribe to Email Alerts
ASX Announcements
Heading &
Sub-heading can be edited through HQI
Investors
>
ASX Announcements
Investor Overview
ASX Announcements
Annual & Financial Reports
Presentations
Share Price Information
AGM
INOVIQ Fact Sheet
Corporate Governance
Shareholder Services
FAQ
Analyst Reports
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
31-Oct-2018
Ceasing to be a substantial holder
31-Oct-2018
Quarterly Activities Report and Cashflow
30-Oct-2018
Notice of Annual General Meeting/Proxy Form
29-Oct-2018
Change in substantial holding
24-Oct-2018
Becoming a substantial holder
24-Oct-2018
Grant of Additional Chinese Patent Core BARD1 Patent Family
23-Oct-2018
Development of world first BARD1 Breast Cancer Test
1-Oct-2018
Appendix 4G
1-Oct-2018
Annual Report to Shareholders
20-Sep-2018
Investor Presentation and Update
Previous
1
2
3
4
5
6
Next
